EFDID: 24164EFD: View Filing

Issuer: ACELRX PHARMACEUTICALS INC (0001427925) - D

Accession: 0001427925-10-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001427925
  • Entity Name:
    ACELRX PHARMACEUTICALS INC
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    575 CHESAPEAKE DRIVE
    REDWOOD CITY, CA 94063
  • Persons:
    Related Persons 11
    Richard King
    Executive OfficerDirector
    Pamela Palmer
    Executive OfficerDirector
    Carter King
    Executive Officer
    Larry Hamel
    Executive Officer
    Anil Dasu
    Executive Officer
    Linda Judge
    Executive Officer
    Howie Rosen
    Director
    Guy Nohra
    Director
    Stephen Hoffman
    Director
    Mark Wan
    Director
    Thomas Schreck
    Director
EDGAR: Offering Information
  • Accession Date:
    09/20/2010
  • First Sale Date:
    09/14/2010
  • Offering Amount:
    $12,001,200
  • Amount Sold:
    $8,000,800
  • Amount Remaining:
    $4,000,400
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
  • Sales Clarification:
    Promissory Notes convertible into Preferred Stock; Warrants to purchase Preferred Stock
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
ACELRX PHARMACEUTICALS INC/s/ Mark B. WeeksMark B. WeeksSecretary2010-09-20